SCHEMBL20152155

SCHEMBL20152155

c1cc(-c2nc(-c3ccc4ccccc4c3)c3ccccc3n2)cc(-n2c3ccccc3c3c4c5ccccc5n(-c5cccc(-c6nc(-c7ccc8ccccc8c7)c7ccccc7n6)c5)c4ccc32)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ATM Q13315 1/20 0.41
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37
CYP1A2 P05177 3/20 0.36
CYP3A4 P08684 3/20 0.36
CYP2C9 P11712 3/20 0.36
NR1I3 Q14994 3/20 0.36
CYP2B6 P20813 2/20 0.36
AHR P35869 2/20 0.36
VDR P11473 1/20 0.36
ABCG2 Q9UNQ0 4/20 0.35
ADORA2A P29274 3/20 0.35
WHR1 P49842 1/20 0.34
GAA P10253 1/20 0.34
CYP2D6 P10635 2/20 0.34
USP2 O75604 1/20 0.34
ALOX15 P16050 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20152154 0.99 MEN1 (0.43) MEN1KMT2AATMAURKAAURKB
SCHEMBL19654051 0.99 ATM (0.41) MEN1KMT2AATMAURKAAURKB
SCHEMBL20152202 0.96 ATM (0.44) MEN1KMT2AATMAURKAAURKB
SCHEMBL20152153 0.96 ATM (0.44) MEN1KMT2AATMAURKAAURKB
SCHEMBL17533326 0.94 MEN1 (0.42) MEN1KMT2AATMAURKAAURKB
SCHEMBL20152157 0.94 ATM (0.40) MEN1KMT2AATMAURKAAURKB
SCHEMBL20152133 0.94 ATM (0.40) MEN1KMT2AATMAURKAAURKB
SCHEMBL19653993 0.94 MEN1 (0.41) MEN1KMT2AATMCYP1A2CYP3A4
SCHEMBL21161312 0.91 ATM (0.41) MEN1KMT2AATMAURKAAURKB
SCHEMBL17017672 0.91 MEN1 (0.37) MEN1KMT2AATMAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662196-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-05-26 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662196-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, SLCO4C1 MEN1 4244/4885KMT2A 3996/4885ATM 2986/4885
US-20180134718-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, SLCO4C1 MEN1 4244/4885KMT2A 3996/4885ATM 2986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.